PTX3 and cardiovascular disorder: However, most studies linking Pentraxin-3 to negative outcomes are clinical observational and associate the molecule to endothelial dysfunction [457,460], cardiovascular disease [455,456,457,460,461], protein energy wasting [455,457] and in a study focusing on the elderly, also incident CKD [462].